Impact ledger
Arrowhead Pharmaceuticals, Inc. (ARWR)
3 events mapped to this ticker since 2026-06-17.
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-07-14 | Event | Indirect competitive pressure or validation of therapeutic approaches. Similar to Moderna, advancements in novel drug classes can influence broader biotech investment trends and competitive dynamics. | watch | 3-12m | 0.20 |
| 2026-06-29 | Event | Indirect sentiment impact on companies developing therapies for similar inflammatory/immunological conditions, especially those in earlier stages. | watch | 1-3m | 0.30 |
| 2026-06-17 | Event | As a company focused on RNA interference (RNAi) therapeutics, positive news in other advanced nucleic acid-based therapies could provide a very slight, indirect boost to sector sentiment. | watch | 3-12m | 0.10 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for ARWR, start a trial or view the ARWR entity page.